SENORES

Senores Pharmaceuticals vs Peers

₹1,390.00+0.10%
Market cap
₹6,401 crore
P/E
50.7
P/B
3.20
ROE
16.4%
Dividend yield
1.20%

Senores Pharmaceuticals ranks 48th by market capitalisation among 71 Pharmaceuticals companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 50.7 compares with a peer median of 33.6.

Senores Pharmaceuticals vs Pharmaceuticals peers

Sorted by market capitalisation.

Senores Pharmaceuticals and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
Sun Pharmaceutical Industries1,773.60-1.69%4,25,54635.25.0914.7%+12.5%
Divi's Laboratories9,586.00+0.38%2,54,47887.015.1816.2%+12.5%
Torrent Pharmaceuticals4,693.90-1.64%1,58,86372.818.9427.1%+12.5%
Zydus Lifesciences1,151.30-0.71%1,15,84825.74.2719.7%+12.5%
Laurus Labs2,052.90+0.14%1,10,827101.420.9118.2%+12.5%
Cipla1,333.00-0.54%1,07,67732.03.1311.8%+12.5%
Mankind Pharma2,496.00-0.16%1,03,04250.46.3212.5%+12.5%
Dr. Reddy's Laboratories1,194.90-1.08%99,53330.12.6012.1%+12.5%
Aurobindo Pharma1,677.90-0.88%97,45326.32.579.9%+12.5%
Lupin2,006.70-1.11%91,74216.64.0926.9%+12.5%
Senores Pharmaceuticals1,390.00+0.10%6,40150.73.2016.4%—

Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.

Senores Pharmaceuticals peer comparison — frequently asked questions

Who are Senores Pharmaceuticals' competitors?

Senores Pharmaceuticals' listed peers in Pharmaceuticals include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs and Cipla, ranked here by market capitalisation.

How does Senores Pharmaceuticals' P/E compare with its peers?

Senores Pharmaceuticals trades at a P/E of 50.7, against a median of 33.6 across the 10 Pharmaceuticals peers shown.

Which is the largest company among Senores Pharmaceuticals' peers?

By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹6,401 crore for Senores Pharmaceuticals.

Same Data For Peers

Trade Senores Pharmaceuticals With ATS

Track SENORES live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.